| Financial Year |
December 31 2020 |
| Monetary Funds |
40,939,302.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
431,603,944.00 |
| Advances to Suppliers |
1,293,485.33 |
| Other Receivables |
10,142,363.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,042,832.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,449,164.62 |
| Total Current Assets |
519,471,092.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
22,632,621.90 |
| Under-construction Projects |
337,620,131.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,343,880.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
48,271.82 |
| Deferred Income Tax Assets |
19,473,157.85 |
| Other Non-Current Assets |
2,740,440.96 |
| Sub-Total of Non-Current Assets |
428,858,504.37 |
| Total Assets |
948,329,596.83 |
| Short-Term Loans |
77,351,664.37 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
142,733,380.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,762,964.98 |
| Taxes Payable |
25,363,424.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,008,397.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
68,095.36 |
| Sub-Total of Current Liabilities |
262,091,686.64 |
| Long-term Loans |
134,320,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,952,336.59 |
| Special Payable |
-- |
| Estimatied Liabilities |
401,842.35 |
| Deferred Income Tax Liabilities |
2,829,405.97 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
235,895,930.20 |
| Total Liabilities |
497,987,616.84 |
| Paid-In Capital(Or Share Stock) |
63,000,000.00 |
| Capital Surplus |
167,442,669.88 |
| Surplus Reserve |
13,888,745.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
204,915,057.34 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
450,341,979.99 |
| Owner's Equity（Stockholder's Equity） |
450,341,979.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
948,329,596.83 |
